These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 19102653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D, Wang D, Zhu FG, Bhagat L, Dai M, Kandimalla ER, Agrawal S.
    J Med Chem; 2009 Aug 27; 52(16):5108-14. PubMed ID: 19650625
    [Abstract] [Full Text] [Related]

  • 3. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 Aug 27; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]

  • 4. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM, Al-Khairy D, Ingalls RR.
    Biol Reprod; 2006 May 27; 74(5):824-31. PubMed ID: 16421230
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
    Haas T, Metzger J, Schmitz F, Heit A, Müller T, Latz E, Wagner H.
    Immunity; 2008 Mar 27; 28(3):315-23. PubMed ID: 18342006
    [Abstract] [Full Text] [Related]

  • 8. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM.
    Cell Immunol; 2004 Mar 27; 232(1-2):64-74. PubMed ID: 15922717
    [Abstract] [Full Text] [Related]

  • 9. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D, Putta MR, Bhagat L, Li Y, Zhu F, Wang D, Tang JX, Kandimalla ER, Agrawal S.
    J Med Chem; 2007 Dec 13; 50(25):6411-8. PubMed ID: 17988082
    [Abstract] [Full Text] [Related]

  • 10. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S, Kandimalla ER.
    Biochem Soc Trans; 2007 Dec 13; 35(Pt 6):1461-7. PubMed ID: 18031246
    [Abstract] [Full Text] [Related]

  • 11. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM, Vollmer J.
    Immunol Rev; 2007 Dec 13; 220():251-69. PubMed ID: 17979852
    [Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
    Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ.
    Immunity; 2006 Sep 13; 25(3):417-28. PubMed ID: 16973389
    [Abstract] [Full Text] [Related]

  • 13. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G.
    J Leukoc Biol; 2007 Sep 13; 82(3):497-508. PubMed ID: 17565046
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
    Senn JJ, Burel S, Henry SP.
    J Pharmacol Exp Ther; 2005 Sep 13; 314(3):972-9. PubMed ID: 15919763
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S, Miyake K.
    Immunol Rev; 2009 Jan 13; 227(1):32-43. PubMed ID: 19120473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.